#GFN18 Programme Committee

Policy, Advocacy and Practice Track
Gerry Stimson Chair
Professor Gerry Stimson is a public health social scientist, with over 40 years’ experience of research and advocacy. He was one of the founders of drugs harm reduction in the 1980s and helped develop and evaluate harm reduction in the UK as a response to HIV/AIDS. He has advised the UK Government, World Health Organization, UNAIDS, UNODC, World Bank and numerous governments on issues relating to drugs, HIV infection and AIDS, and alcohol. He is an advocate for tobacco harm reduction as a key public health strategy for reducing smoking related harms. He was a member of the UK National Institute for Health and Clinical Excellence guidelines group on tobacco harm reduction, and is a member of the British Standards Institute working group on e-cigarette standards. He helps organise the Global Forum on Nicotine conference. He has published over 220 scientific publications and several books. He is Honorary Professor at the London School of Hygiene and Tropical Medicine, Emeritus Professor at Imperial College London, and recent past Editor of the International Journal of Drug Policy. He was Executive Director of the International Harm Reduction Association from 2004 to 2010.
Colin Mendelsohn
Colin Mendelsohn is an Associate Professor in the School of Public Health and Community Medicine at the University of New South Wales, Sydney, Australia. He is a medical practitioner and tobacco treatment specialist working in private practice and is Chairman of the Australian Tobacco Harm Reduction Association. He is actively involved in raising awareness of the public health benefits of tobacco harm reduction and advocating for the legalisation of vaping in Australia. His activities in the smoking cessation field include teaching medical students and health professionals, writing, research, public education and consulting to the pharmaceutical industry. Colin is a member of the committee that develops the Australian national smoking cessation guidelines and is past Vice President of the Australian Association of Smoking Cessation Professionals.
Gillian Golden
Gillian Eva Golden comes from a background in the creative, customer service, and retail sectors. A former smoker thanks to discovering vaping in 2012, she now works as administrator for the Irish Vape Vendors Association, Ireland's only trade association for independently owned, specialised retailers of vaping products. She not only advocates for vaping as a means of tobacco harm reduction, but also for industry stewardship, and sits on the Technical Committee of CEN TC 437 for electronic cigarettes and e-liquids.
Olivier Théraulaz
Olivier Théraulaz is the International Network of Nicotine Consumer Organisations (INNCO) Strategic & financial Officer and Chairman of Helvetic Vape, Switzerland. Long-time smoker, Olivier Théraulaz learned in 2013 that the Swiss prohibition on vaping products containing nicotine concerned only sales and that importations for personal use was allowed. He immediately switched to vaping and stopped smoking in less than one week without giving up his pleasure. Convinced of the potential of vaping for public health, he started to advocate for the modification of the absurd Swiss administrative rules about vaping and the dissemination of clear and objective information about risk and harm reduction. He now also advocates for nicotine users'rights at international level through INNCO.
Rajesh Sharan
Rajesh N. Sharan, Ph. D., is a Professor at Department of Biochemistry and Director of Design Innovation Center at North-Eastern Hill University, Shillong (India). Rajesh is a Molecular Biologist and Biochemist by training with over 3 decades of research experience in the field of betel (Areca) nut & chemical induced carcinogenesis, and molecular mechanisms of radiation induced damage to DNA & its repair with expertise in biomarker discovery for cancer and radiation damage assessment for their clinical applications. Rajesh is a former President of Indian Society for Radiation Biology and currently a member of CRP of IAEA (Vienna). He has over 105 research publications & books, and few patents to his credit. Rajesh serves as an Associate Editor of the Journal of Radiation Research. Since last year, Rajesh has developed keen interest in the field of tobacco harm reduction in India and initiated research in this area.
Cynthia Cabrera
Cynthia Cabrera is a seasoned expert in the vapor space,involved in the vapor industry since 2011. As Founder and president of The Cating Group, Cynthia and her team provide business-consulting services including compliance, manufacturing operations, restructuring, government affairs, and business development including new product rollout and strategic partnerships. She is a frequent speaker on trends, product evolvement, distribution channels, and regulatory and legislative issues. Cynthia has presented for The Tobacco Merchants Association (TMA), The Global Tobacco Nicotine Forum (GTNF), the Global Forum on Nicotine (GFN), The Food & Drug Law Institute (FDLI,), The Responsible Retailers Forum (RRF), ECIG USA, the Morven Dialogues and a wide variety of vapor shows and exhibits.
Robyn Gougelet
Robyn Gougelet
Robyn Gougelet is responsible for conducting public policy analysis, advising on public health legislative and regulatory policy strategy, helping to draft public health rationales, and advising clients on tobacco harm reduction efforts. Before joining PinneyAssociates as an Associate in June 2015, Robyn worked for three years at Trust for America’s Health (TFAH), a non-profit, non-partisan organization in Washington, D.C. dedicated to saving lives by protecting the health of every community and working to make disease prevention a national priority. In that role, Robyn helped to inform Members of Congress and their staff about state-specific prevention and public health provisions and programs created by the Affordable Care Act. As part of her work at TFAH, Robyn advocated for public health programs during the appropriations process. Before joining TFAH, Robyn worked as an intern in the office of Senator Jeanne Shaheen. Robyn graduated magna cum laude from the University of Maryland with an honors degree in History and was elected to Phi Beta Kappa. As an undergraduate, she also studied history and politics as a visiting student at Lady Margaret Hall at the University of Oxford.
Miroslaw Dworniczak
Miroslaw Dworniczak, PhD - chemist, freelance science journalist, former scientist and lecturer at the Department of Chemistry, Adam Mickiewicz University (Poznan, Poland). Author (under the name "Stary Chemik" - "Old Chemist") of the first blog in Poland dealing with e-cigarettes and e-liquid chemistry and safety (https://starychemik.wordpress.com/ - in Polish).

Science Track

Caitlin Notley Chair
Dr Notley is a Senior Lecturer in Mental Health at the Norwich Medical School, University of East Anglia, and a Research Fellow of the UK Society for the Study of Addiction. She is a social scientist with extensive experience in Addiction research. Her current programme of research is focused on tobacco smoking relapse prevention, particularly working with vulnerable groups. Dr Notley’s research interests in alternative nicotine delivery devices primarily explores social and culturally pertinent aspects of vaping. Her work emphasises the public health potential of vaping for smoking relapse prevention, taking a ‘real world’ perspective to highlight the importance of user focused perspectives on switching from traditional smoking to vaping. Dr Notley, as Chair of the Scientific Committee, has an independent role in overseeing the scientific content of the conference. The role includes assessment of the Early Career Travel Awards which are funded from the GFN conference budget. Dr Notley receives no funding for this voluntary role.
Helen Redmond
Helen Redmond, is an expert in substance use with over a decade of experience working with drug users and people with mental health problems in medical and mental health settings and in community supportive housing. Her current focus is on helping vulnerable and stigmatized populations transition to e-cigarettes. She is an independent journalist and writes about vaping, mental health and drug policy. Helen is a filmmaker and made a short documentary about people with serious mental health problems and smoking. She provides tobacco harm reduction trainings via her consulting firm, Nicotine Harm Reduction Consultants. She is adjunct faculty at New York University - Silver School of Social Work.
Leon Kośmider
Leon Kosmider is a post-doctoral fellow working in the Bioanalytical Laboratory within Department of Pharmaceutics, School of Pharmacy, and affiliated with Center for the Study of Tobacco Products, both located at Virginia Commonwealth University.
After Dr Kosmider received his Pharm.D, he earned his PhD in Pharmacy and Toxicology from Medical University of Silesia, Poland. Conducted research in toxicology of tobacco products involving various tobacco products: e-cigarettes and cigarettes. Studied smoking topography and yields of toxic agents in tobacco smoke and e-cigarette vapor generated in various smoking conditions. Principal Investigator for design and construct smoking machine - Palaczbot. Involved in standard development for electronic cigarettes and e-liquids as an expert of Polish National Committee for Standardization.
Ryan Courtney
Dr Courtney is a Cancer Institute New South Wales Early Career Research Fellow at the University of New South Wales (UNSW), National Drug and Alcohol Research Centre and current Margaret Hamilton Award recipient for outstanding research achievement in drug and alcohol research. Dr Courtney’s published work includes research on smoking cessation, in particular tobacco smoking in socially disadvantaged groups. His research has a strong intervention focus and is aimed at reducing the social gradient in smoking cessation. Dr Courtney is an investigator on over $4.8 million in competitive research funding nationally and internationally including the following projects: (i) RCT to test the efficacy of reducing financial stress to increase smoking cessation; (ii) world-first head-to-head RCT of cytisine vs varenicline for smoking cessation; (iii) relapse prevention RCT testing the efficacy of electronic cigarettes; RCT on the cost-effectiveness of technology-based interventions to increase treatment adherence and smoking cessation; (iv) CI on other Category 1 funded grants, including the impact of electronic nicotine device use in youth cohorts.
Sharon Cox
Dr Sharon Cox has over ten years’ experience working in the drug and alcohol field, including working at front-line services with some of the UK’s most deprived communities. She has a special interest in harm reduction and the use of translational methodologies in vulnerable and marginalised groups. She currently works as a Research Fellow at London South Bank University’s Centre for Addictive Behaviours Research. Her current research is focused on e-cigarette puffing patterns associated with high and low nicotine e-liquid strength, smoking and alcohol consumption within disadvantaged groups and the impact of health warning labels on reduced risk products.
Karl Lund
Professor Karl E. Lund, Research Director of the Tobacco Unit at the Norwegian Institute for Public Health. He has been involved in tobacco control work since the mid 1980s, working at the Norwegian Council on Tobacco or Health (Deputy Leader), the Norwegian Cancer Society (Director for Department of Cancer Prevention) and Norwegian Institute for Alcohol and Drug Research (Research Director). Dr. Lund received the Norwegian Medical Association’s Award in preventive medicine in 2002. He is well published within tobacco research, has been a lecturer on tobacco topics in several countries worldwide, and has been a member of several expert committees on tobacco control including WHO’s International Agency for Cancer Research (IARC). He has been an expert witness in several court cases against the tobacco industry in Norway. Dr. Lund has been Associate Editor in the scientific journal Nicotine & Tobacco Research since 2011 and Senior Associate Editor of Tobacco Regulatory Science since 2015.
Konstantinos Farsalinos
Konstantinos E. Farsalinos, M.D., is a research fellow at the Onassis Cardiac Surgery Center in Athens-Greece, at the Department of Pharmacy, University of Patras-Greece and at the National School of Public Health-Greece. He has been conducting laboratory and clinical research on e-cigarettes as a principal investigator since 2011. Examples of his work include the first study on the cytotoxic effects of e-cigarette vapor on cultured cells and the immediate effects of e-cigarette use on cardiac function and coronary circulation. He ran a worldwide online survey of almost 20,000 vapers (users of e-cigarettes) identifying patterns of use and experience with e-cigarettes among consumers, published in 2014. He has analyzed patterns of e-cigarette use based on large European and US population surveys (Eurobarometer, National Youth Tobacco Survey). Additionally, he is performing research work on heated tobacco products. His research findings have been presented in major international scientific congresses and his studies were used in preparing the regulatory framework on e-cigarettes by the European Union. As of early 2018, he has published more than 60 studies and articles in international peer-reviewed scientific journals about smoking, tobacco harm reduction, and e-cigarettes. He was the handling editor and author in a book titled "Analytical assessment of e-cigarettes", published by Elsevier in 2017.
Raymond Niaura
Raymond Niaura, Ph.D., is director of Science at the Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, where he also oversees the pre- and post-doctoral training program. He is an adjunct professor in the Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health and an adjunct professor at the Georgetown University Medical Center. Professor Niaura has been awarded numerous grants from the National Institutes of Health, several foundations and private industry for his research work. His focus is the study of combined pharmacological and behavioral treatments to aid smoking cessation, with a particular interest in cessation in disadvantaged populations. He has published more than 300 peer-reviewed papers, is deputy editor of Nicotine and Tobacco Research, and has authored several individual book chapters as well as co-authored the book “The Tobacco Dependence Treatment Handbook: A Guide to Best Practices.” He is a past president of the Society for Research on Nicotine and Tobacco.

Consumer engagement

Judy Gibson
Since gaining her Brownie Wings in the 60’s, Judy Gibson has had an eclectic career including: WRAF Aircraft mechanic, drill instructor, restaurant manager, detective sergeant, MOD/MI5 gopher, Computer Consultant, twenty years in artiste management, theatre marketing/film programming and finally a Community Flood Consultant before reaching the zenith that is INNCO. A Jill of all trades and occasional mistress seems to cover it. A smoker since the invention of bike-sheds, Judy tried vaping about six years ago, reducing smoking but struggling with e-cigarette incarnations until, in 2015, technological improvements tipped the scales. Having finally eschewed cigarettes, she was astounded to discover that despite vaping being significantly safer, others were demanding draconian regulations and prohibition. Thus, a vociferous advocate for tobacco harm reduction was born. When not engaged in rebutting the latest vaping ‘research’ scare stories, overzealous state regulation or the latest calls for banning every e-liquid flavour except tobacco (the irony), she might be found nursing a large ‘Rakish Rhubarb Gin’, ambivalent to the rampaging brambles in her cottage garden.